Showing results (61-70 of 80) with videos related to
Sort By:
Pageof 8
The Journal of Endocrinology|September 28, 2006
The involvement of epoxygenase metabolites of arachidonic acid in cAMP-stimulated steroidogenesis and steroidogenic acute regulatory protein gene expressionXingjia Wang, Chwan-Li Shen, Matthew T Dyson, et al.Endocrinology|March 28, 2009
Involvement of the thromboxane A2 receptor in the regulation of steroidogenic acute regulatory gene expression in murine Leydig cellsAkhilesh K Pandey, Xiangling Yin, Randolph B Schiffer, et al.Biochemistry and Biophysics Reports|December 9, 2020
Short-term treatment with dabigatran alters protein expression patterns in a late-stage tau-based Alzheimer's disease mouse modelJaclyn Iannucci, Shelby L Johnson, Mark Majchrzak, et al.Journal of Alzheimer'S Disease : JAD|August 14, 2012
p38 MAPK: a mediator of hypoxia-induced cerebrovascular inflammationAlma Sanchez, Debjani Tripathy, Xiangling Yin, et al.The Journal of Endocrinology|April 25, 2008
Chrysin, a natural flavonoid enhances steroidogenesis and steroidogenic acute regulatory protein gene expression in mouse Leydig cellsKuladip Jana, Xiangling Yin, Randolph B Schiffer, et al.Clinical Nutrition (Edinburgh, Scotland)|May 16, 2013
Lipid content in hepatic and gonadal adipose tissue parallel aortic cholesterol accumulation in mice fed diets with different omega-6 PUFA to EPA plus DHA ratiosShu Wang, Nirupa R Matthan, Dayong Wu, et al.Journal of Alzheimer'S Disease : JAD|February 8, 2014
A new paradigm for the treatment of Alzheimer's disease: targeting vascular activationPaula Grammas, Joseph Martinez, Alma Sanchez, et al.Biochemical and Biophysical Research Communications|June 9, 2004
Anti-inflammatory effects of tocopherol metabolitesPaula Grammas, Ladan Hamdheydari, Elaine J Benaksas, et al.Journal of Alzheimer'S Disease : JAD|September 11, 2018
A Precision Medicine Model for Targeted NSAID Therapy in Alzheimer's DiseaseSid E O'Bryant, Fan Zhang, Leigh A Johnson, et al.Frontiers in Aging Neuroscience|September 7, 2018
Blood-Cerebrospinal Fluid Barrier Gradients in Mild Cognitive Impairment and Alzheimer's Disease: Relationship to Inflammatory Cytokines and ChemokinesBrian R Ott, Richard N Jones, Lori A Daiello, et al.Pageof 8